research use only
Cat.No.S7297
| Related Targets | VEGFR FGFR PDGFR c-Met Src MEK CSF-1R HER2 FLT3 c-Kit |
|---|---|
| Other EGFR Inhibitors | Icotinib Hydrochloride Sunvozertinib AG-490 AG-1478 Canertinib (CI-1033) Genistein Rociletinib (CO-1686) Poziotinib (NOV120101, HM781-36B) WZ4002 PD153035 HCl |
|
In vitro |
DMSO
: 99 mg/mL
(198.15 mM)
Ethanol : 99 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about AZD9291 (Osimertinib) solubility in DMSO or water
Read more about AZD9291 (Osimertinib) working concentrations for cell culture treatment
| Information | AZD9291 (Osimertinib) is a potent, selective, irreversible ATP-competitive mutant EGFR inhibitor. It affects MAPK/ERK and PI3K/AKT signaling by covalently binding to the Cys797 residue to block autophosphorylation, effectively inhibiting tumor cell proliferation and inducing apoptosis. |
|---|---|
|
Read more about AZD9291 (Osimertinib) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 499.61 | Formula | C28 H33 N7 O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1421373-65-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Mereletinib | Smiles | CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
Can this formulation be used in mice? What are its reconstitution instructions for in vivo with mice?
Answer:
It can be used for animal study. The vehicle we suggest is: 5%DMSO+40%PEG300+5%Tween 80+50%ddH2O.